- Home
- FBLG vs NTIP Comparison
FBLG vs NTIP Comparison
Compare FBLG & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLG
- NTIP
- Stock Information
- Founded
- FBLG 2021
- NTIP 1990
- Country
- FBLG United States
- NTIP United States
- Employees
- FBLG N/A
- NTIP N/A
- Industry
- FBLG
- NTIP Multi-Sector Companies
- Sector
- FBLG
- NTIP Miscellaneous
- Exchange
- FBLG NYSE
- NTIP Nasdaq
- Market Cap
- FBLG 37.1M
- NTIP 32.0M
- IPO Year
- FBLG 2024
- NTIP 1998
- Fundamental
- Price
- FBLG $0.63
- NTIP $1.42
- Analyst Decision
- FBLG Strong Buy
- NTIP
- Analyst Count
- FBLG 4
- NTIP 0
- Target Price
- FBLG $13.00
- NTIP N/A
- AVG Volume (30 Days)
- FBLG 480.7K
- NTIP 35.4K
- Earning Date
- FBLG 08-11-2025
- NTIP 08-11-2025
- Dividend Yield
- FBLG N/A
- NTIP 7.07%
- EPS Growth
- FBLG N/A
- NTIP N/A
- EPS
- FBLG N/A
- NTIP N/A
- Revenue
- FBLG N/A
- NTIP $250,000.00
- Revenue This Year
- FBLG N/A
- NTIP N/A
- Revenue Next Year
- FBLG N/A
- NTIP N/A
- P/E Ratio
- FBLG N/A
- NTIP N/A
- Revenue Growth
- FBLG N/A
- NTIP N/A
- 52 Week Low
- FBLG $0.58
- NTIP $1.16
- 52 Week High
- FBLG $5.54
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- FBLG 42.37
- NTIP 63.69
- Support Level
- FBLG $0.61
- NTIP $1.40
- Resistance Level
- FBLG $0.72
- NTIP $1.46
- Average True Range (ATR)
- FBLG 0.06
- NTIP 0.05
- MACD
- FBLG 0.00
- NTIP 0.00
- Stochastic Oscillator
- FBLG 35.48
- NTIP 78.95
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.